chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 minutes after receiving the vaccine my throat started feeling tight. I waited 1 minute to make sure it wasn?t going to go away. I motioned for the security officer to come over so I could tell him my throat felt tight, I was dizzy and lightheaded. He called for a nurse.  Several people came over to check on me, take my vitals, ask questions and administer an EpiPen. They noticed I was very pale. I felt better for about 1 min but symptoms came back. An ambulance was dispatched. They came and took vitals as well. I was then loaded into the ambulance and transported to the hospital. Vitals were again taken. I was monitored and blood was drawn. Blood work came back that I had low potassium so I was given an infusion of that. I was sent home with a script for Famotidine 20mg, Fexofenadine 180mg and Klor-Con M20. Around 7:45pm I felt my throat tightening again so I took the 2 meds for the allergic reaction. Throat still feels tight at 8:57pm but not as bad as it did at 7:45pm.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a unk patient who received SHINGRIX (batch number UNKNOWN, expiry date unknown). On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain and incorrect storage of drug. On an unknown date, the outcome of the injection site pain and incorrect storage of drug were unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not reported. The reporter was patient's son calling to ask about information in regards to SHINGRIX vaccine that was stored in the freezer by the pharmacy and was administered to the patient, which led to incorrect storage of vaccine. He reported that his father had been experiencing pain at the injection site reaction for about a week by the time of reporting. The patient received a call from his pharmacy that SHINGRIX that was administered to him was stored in the freezer and he needed to go back in to get a new dose. The patient had denied permission to contact their physician. The reporter had very limited information, and wanted to hold on to providing information for the adverse event report. The reporter was referred to have their health care provider or pharmacist call GlaxoSmithKline medication information department for further data.
evening around 4p.m. after the vaccine  Adverse effect- lethargy, sleepy 03/23/21 felt cold, swollen lip and face, lethargy, sleepy  Ever have a reaction to a previous vaccine?  If yes, what? no- usually gets 3 vaccines each month for allergies she didnt take the third dose this month because she was getting the COVID vaccine, area of injection usually gets swollen when she gets these vaccines and it goes away within a few hours     Recommendations: please contact your PCP for recommendations since he has your medical records available, see what he recommends for you to take whether it be your prescribed allergy medication or any OTC items. If you are currently experiencing any Shortness of breath please visit your nearest Emergency Department, otherwise inform your PCP that you are experiencing swelling on your lips and that you experienced a swollen face that subsided. Consult with him on whether you should or shouldn't get the second dose vaccine, one of the contraindications for the vaccine is anaphylaxis so its better to take precaution.
BRACHIAL PLEXITIS (RIGHT ARM); This spontaneous report received from a patient via a company representative concerned a 40 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-JUL-2021, the subject experienced brachial plexitis (right arm). Laboratory data (dates unspecified) included: Blood test (NR: not provided) Excluded Lyme Disease, Electromyogram (NR: not provided) Confirmed Brachial Plexitis, most like due to vaccination, Magnetic resonance imaging head (NR: not provided) Negative for signs of stroke or other issues, and Magnetic resonance imaging neck (NR: not provided) Negative for signs of stroke or other issues. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of brachial plexitis (right arm) was not reported. This report was non-serious.
Large red blotch covering upper arm. Sore, then itchy. Went away, now back again.
intractable seizures was loaded with anti seizure meds in ER and admitted to the hospital to further get seizures under control
Patient felt faint few minutes after receiving vaccine.  VSS, not syncopal.  Patient moved to an exam room and recuperated shortly afterwards.  Seen by provider, and discharged home approx 30 min afterwards.
Narrative: 61yo male with hx of obesity, ED, pre-DM, PVD, HDL, tobacco use, & umbilical hernia died on 7/15/2021. Pt died at home per sister. No other details mentioned regarding pt's death. Pt had received covid vaccinations on 3/11/21 & 4/8/2021. Likely pt's death is not related to the vaccinations given death was >90 days post last covid vaccination.
After receiving a vaccine patient became disoriented fainted and exhibit muscle spasms. Treat it with Aromatic ammonia salt and water. Upon arrival of EMS patient got some glucose as well. Last report he was felling better, EMS took patient to the bus for check up. Unknown if patient went to the emergency room.
Got shingles from the shot/suspected vaccination failure; Got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shingles from the shot/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 11-MAR-2023 The case was received from the patient interactive digital media. The patient got shingles from the Shingles shot.  The patient stated that now he/she get it about every 6 months or so. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
pt recv rabies shot 22JUN95; evening of 23JUN95 pt had nausea & head hurt; lasted through next day;  VAERS form TX95153
This spontaneous report as received from a consumer refers to his daughter, a 12 year old female patient. In November 2012 the patient was vaccinated with the first dose of GARDASIL (lot # not reported). The patient's arm (left or right not specified) became swollen on the evening after the injection. The symptoms eventually subsided. (Timeframe not specified). The second dose of GARDASIL (lot # not reported) was administered (time not specified) and the patient's arm became swollen again. The patient did not seek medical attention. No treatment was given. The reporter (Father) stated the patient had fully recovered. Additional information is not expected.
This spontaneous report as received from a doctor of pharmacy refers to a patient of unknown age who on 19-JUL-2012, was vaccinated with a dose of ZOSTAVAX that was expired (dose, route, lot number and expiration date not reported). No symptoms were reported. Additional information has been requested.
Mild fever 99.5F; headache; This is a spontaneous report from a non-contactable Other Health Professional. A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on 12Jan2021 at single dose on arm left for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced mild fever 99.5 F and headache, both on 13Jan2021 with outcome of unknown.  Patient did not have COVID prior vaccination. Patient did not have COVID tested post vaccination.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Pain at the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Feb2021 as dose 2, single (Lot number: EL9266) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "hyper- cholesterolemia" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN, stop date: 05Aug2022. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Batch/Lot No: EL9265; Anatomical location: Arm Left), administration date: 28Jan2021, when the patient was 64-year-old, for COVID-19 Immunization, reaction(s): "Pain at the injection site". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "Pain at the injection site".  Additional information: The patient received BNT162b2 (BNT162B2) on 29Sep2021 as dose 3 (booster), single (Lot number: 301458A)  in left arm for covid-19 immunisation and on 25Jun2022 as dose 4 (booster), single (Lot number: FP7135)  in left arm for covid-19 immunisation. The patient had no known allergies. It was reported that there were none other than pain at the injection site.
A report has been received from a Pharmacist concerning an Adult, male subject, who had been receiving FLUMIST (INTRANASAL). FLUMIST(INTRANASAL) started on 08-Jan-2013. The patient experienced BLOOD BLISTER ON THE ARM which started on 12-Jan-2014. FLUMIST (INTRANASAL) was discontinued on 08-Jan-2014. The patient recovered from the event of BLOOD BLISTER ON THE ARM on 16-Jan-2014. The report was considered to be non-serious by the reporter. The reported case causality was considered between the event of BLOOD BLISTER ON THE ARM and the suspect drug of FLUMIST to be Yes. Summary of follow-up information received by AstraZeneca/MedImmune 04-Feb-2014 from a Pharmacist dose and frequency added, lot number, patient's initials and date of birth added, medical history and reported case causality added.
No Adverse event; Patient had taken first dose on 03-JAN-2022 and second dose on 22-MAY-2022.; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had taken first dose on 03-JAN-2022 and second dose on 22-MAY-2022.) and NO ADVERSE EVENT (No Adverse event) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 033C21A and 013H21B) for COVID-19 prophylaxis.     Concurrent medical conditions included RA and Sulfonamide allergy.   On 03-Jan-2022 at 9:00 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-May-2022 at 2:00 PM, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 22-May-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had taken first dose on 03-JAN-2022 and second dose on 22-MAY-2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient had taken first dose on 03-JAN-2022 and second dose on 22-MAY-2022.) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Redness and slight swelling 5 in x 4.5 inches center area slight vesicle area. Center area slight warm but pt denies pain.
Pt recv vax on 7/31/98; 30 min later pt exp nausea &vomiting, loss of skin color, fever (103) x 2 day
I have not been able to sleep or rest since getting the vaccine. My body feels like it is racing like on lots of caffeine. That speedy feeling. I have the normal side effects as well, headache, nausea, fatigue...
WITHIN 24 HRS hoarse, sore throat, congestion, headache, muscle aches, site inflammation, runny nose, fatigue - still present 4 days later
Pt began to feel lightheaded and flushed about 2 minutes after receiving vaccine. Pt noted to be diaphoretic. BP 119/78, HR 75 and 100% on RA. Pt states that she was anxious about receiving the vaccine prior to.  Pt given some water and placed in trendelenburg position. Within about 10 minutes, pt recovered and felt back to baseline. Pt observed by RN for approximately 30 minutes.
Received vaccine when 20 weeks pregnant. After vaccine, started feeling heart palpitations. The following evening felt heart palpitations, tachycardia, dizzy, shaky, and impending sense of doom. Called 911. Vitals (blood pressure, heart rate, oxygenation, temperature), blood glucose, and heart rhythm were normal. No interventions made. Continued to have intermittent palpitations the following 2 weeks.
Patient reported arms and legs being itchy approx. 10 min post-injection. Administered 50mg Benadryl orally. Patient also complained of tightness in throat, which improved after Benadryl. Vitals did not indicate anaphylaxis, continued to monitor BP over course of symptom reporting. Also applied ice pack to left forearm and back of neck. EMTs arrived to check vitals and reported no signs of anaphylaxis, inquired if patient wanted to return home or wanted to get higher level of care, and she chose to go to the hospital. There, the providers found no emergent medical issues.   Nurse called and checked on patient 4pm same day, the patient reported no issues and all concerns were resolved.
arm pain in both arms; Rapid heart beat; A spontaneous report was received from a consumer concerning a 84 years female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events of rapid heart beat and arm pain.  The patient's medical history included arthritis. No relevant concomitant medications were reported.  On 23JAN2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot/Batch: 029L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 23JAN2021, the patient  experienced rapid heart beat for hours and resolved on the same day. On 30JAN2021, she had arm pain when she lifts her arm over her head in both arms but greater in the left where she had the injection.  She does have a history of arthritis but has not had this pain prior to the vaccine.  There was no treatment information provided.  Laboratory details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event of rapid heart beat was resolved on 23JAN2021.  The outcome of the event of arm pain was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient's age and history of arthritis may confound causality assessment.  Further information has been requested.
Approximately five minutes after receiving a COVID vaccine patient c/o heart beating fast. She had no complaints of trouble breathing, tongue or throat swelling, or rash. There were no hives, rash, wheezing, flush. Patient was alert, NAD. BP 116/74, P74 O2 sat 94%. Patient observed for 40 minutes. No further episodes of rapid heart rate. BP upon discharge was 135/73, P 64 and O2 Satu 96%
Narrative:  Pt reported rash, nausea, fatigue after receiving Johnson and Johnson vaccine.
Pt received Pfizer dose #1. Waited the allotted 15min time after receiving. No complaints of adverse effect monitored by doctor. Pt called in to triage Nurse RN 9am 5/5/2021. c/o Headache, sore throat, tingling in arm and face. MD sent pt to ER for f/u related to tingling in arm and face. Pt informed Headache and sore throat possible side effect of Covid vx..
Rash broke out on chest the day after first dose and became worse after second dose. Rash went halfway up neck to each collar bone (not all the way to arms or top of shoulders), and down to just above breasts. Itchy, but not painful.  The rash is still present and skin still appears red sometimes. I will have to see a doctor soon.
Moderna COVID-19 Vaccine EUA. Chills, muscle aches, extreme fatigue.
I received the Moderna COVID-19 vaccine on Tuesday, December 29th at work and on Wednesday, December 30th when I woke up my entire neck had broken out in hives. I did not have hives anywhere else or any other reaction. After taking 25 mg of Benadryl po and applying hydrocortisone cream, the hives had cleared up about 75%. I continued to use the hydrocortisone cream throughout the day, but the hives/redness had fully cleared up by Saturday, January 2nd.
contracted Covid-19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (contracted Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A. and 939902) for COVID-19 prophylaxis.     No Medical History information was reported.   On 02-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (contracted Covid-19). At the time of the report, COVID-19 (contracted Covid-19) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The patient received her first dose of Moderna Covid-19 vaccine on 2OCT2021 lot number 939902 expiration date was not known. No expiration date was provided. The caller reports that her daughter contracted Covid-19 at some point after the first dose. The patient received her second dose of the Moderna Covid-19 vaccine on 30OCT2021 lot number 004F21A. No expiration date was provided. Caller was not sure if her daughter had any adverse reactions. The caller said that she did not know if her daughter received any Moderna booster doses. No treatment was reported.
Employee received influenza vaccine at 2pm on 9/25/12. Localized reaction of redness, swelling, warmth, pain noted at 7pm. On 9/26/12, awoke at 5AM with pain & stiffness to left side of neck, upper back, shoulder & left arm along with a dull headache.
Information has been received from a nurse on 11-FEB-2015 referring to a patient of unknown age. On 12-JAN-2015 the patient was vaccinated with a dose of VARIVAX (Merck) injection, 0.5 ml, subcutaneously (lot# was not reported) which underwent a temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Diarrhea, Bone sore, Blood stool, skin rash, loss hair, vision loss, high blood pressure, diabetes, cramps on arms, loss memory sexual impotent
Provider received notification from "NIGHT NURSE: Pediatric After Hours Triage Service"  that Patient had hives develop on her ABDOMEN / ARMS / and THIGH appearing 48 -72 hours after Pfizer COVID Vaccine Administration @ an outside facility.
Mom describes fever for 36 hours post immunizations.  Mom noted bilatanterior thighs were swollen warm and tender to touch after immunizations.  However changes in right thigh resolved, Mom is not certain but believes redness and swelling in Left thigh did not resolve and since 5-11-07 she noted area of redness and warmth gradually larger, denies fever after 1st 36 hours.
28 hrs. after injection: felt like I was getting sick - headache, slight nausea, dizzy and weak. I was awakened at 2 pm w/severe pains in upper hands and wrists. Upon standing, pain in both knees. Pains and feeling sick lasted 1 1/2 days, was taking 3 ADVIL every 4 hrs.
Patient was in the store and I asked how she was and she showed me the injection site.  It was raised.
This initial spontaneous report was received on 15-DEC-2017 from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. The patient was inoculated with ZOSTAVAX on or about 03-OCT-2012, at a pharmacy, (by an unspecified person) as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 25-JUL-2015, the patient was treated by a clinic (by an unspecified person), for the onset of a blistery rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient has been prescribed VALTREX for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, lost wages, pain and suffering, and other damages. The outcome of the events was not resolved. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
Red non raised rash about 2-3 inches in diameter appeared 7 days after injection. Pt states also itches. Not warm or painful.
Bell's palsy; This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long term prevention of shingles and zoster-related condition (the dosage regimen information was not reported). Subsequently, the patient was treated by a healthcare professional for Bell's palsy. As a direct and proximate result of vaccination with zoster vaccine live (ZOSTAVAX), the patient had and would continue suffer ongoing injuries, including but not limited to mental and physical pain and suffering, medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including nut not limited to medical losses and cost include care for hospitalization, physician care, monitoring, treatment, medications, and supplies, diminished capacity for the enjoyment of life, diminished quality of life, increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions, and other losses and damages, and would continue to suffer such losses and damages in the future.  At the time of the report, the patient's outcome was unknown.  Upon internal review, Bell's palsy was considered to be medically significant.
Body soreness and weakness-muscles and joints Fatigue Headache Chills Slept 20 hours after symptoms started